NL13   Click here for help

GtoPdb Ligand ID: 13416

Synonyms: compound 7 [PMID: 39142876]
Compound class: Synthetic organic
Comment: NL13 is reported to behave as an inhibitor of the prostate cancer target, polo-like kinase 4 (PLK4) (IC50 2.3 μM in a biochemical assay) [1]; structure drawn from this Qiao et al. (2024) article with specified (E)/(Z) configuration on the double bonds. Mechanistically, PLK4 inhibitors disrupt mitotic spindle assembly which induces cell cycle arrest and apoptosis.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 0
Rotatable bonds 4
Topological polar surface area 37.38
Molecular weight 400.3
XLogP 2.51
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCC(=O)N1C/C(=C/C2=C(C=CC=C2)Cl)/C(=O)/C(=C/C3=C(C=CC=C3)Cl)/C1
Isomeric SMILES CCC(=O)N1C/C(=C/C2=C(Cl)C=CC=C2)/C(=O)/C(/C1)=C/C3=C(Cl)C=CC=C3
InChI InChI=1S/C22H19Cl2NO2/c1-2-21(26)25-13-17(11-15-7-3-5-9-19(15)23)22(27)18(14-25)12-16-8-4-6-10-20(16)24/h3-12H,2,13-14H2,1H3/b17-11-,18-12+
InChI Key UMURAXCBRUGMLC-MJZABRMRSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Bioactivity Comments
NL13 has demonstrated anti-tumour actions in vitro and in vivo. It induces cell cycle arrest and apoptosis in prostate cancer models and inhibits prostate cancer (PC3 cell) xenograft growth in mice [1].